Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics–related cardiac dysfunction

Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics–related cardiac dysfunction

Abstract Background Cancer therapeutics–related cardiac dysfunction (CTRCD) from different chemotherapy strategies are underdetermined by echocardiography. As an imaging marker of subclinical cardiac dysfunction, two-dimensional speckle tracking echocardiography (2D-STE) may assist in identifying th...

Full description

Bibliographic Details
Main Authors: Wei Liu, Wei Li, Hairu Li, Ziyao Li, Peng Zhao, Zihong Guo, Cong Liu, Litao Sun, Zhenzhen Wang
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cardiovascular Disorders
Subjects:
Two-dimensional speckle tracking echocardiography
Breast cancer
Neoadjuvant chemotherapy
Left ventricular systolic function
Cancer therapeutics–related cardiac dysfunction
Online Access:https://doi.org/10.1186/s12872-022-03007-8

Internet

https://doi.org/10.1186/s12872-022-03007-8

Similar Items